Literature DB >> 7561147

Determination of humanized anti-Tac in human serum by a sandwich enzyme linked immunosorbent assay.

B E Fayer1, P P Soni, M H Binger, D R Mould, H Satoh.   

Abstract

A 'sandwich' enzyme-linked immunosorbent assay has been developed for measuring humanized anti-Tac (HAT), a humanized antibody to the IL-2 receptor on activated T cells (Tac), in human serum. The working range of this assay is 25-400 ng/ml with an overall precision of 5%. In this assay, the analyte, HAT, is sandwiched between Tac which is bound to a microtiter plate and biotinylated Tac that is conjugated to peroxidase labelled streptavidin. This assay was utilized to determine the pharmacokinetic parameters of HAT in patients with graft-versus-host disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7561147     DOI: 10.1016/0022-1759(95)00131-s

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

Review 1.  Daclizumab: a review of its use in the prevention of acute rejection in renal transplant recipients.

Authors:  L R Wiseman; D Faulds
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

2.  7th annual European Antibody Congress 2011: November 29-December 1, 2011, Geneva, Switzerland.

Authors:  Alexey A Lugovskoy; Janice M Reichert; Alain Beck
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

3.  Two doses of humanized anti-CD25 antibody in renal transplantation: a preliminary comparative study.

Authors:  Jing Li; Xinyan Li; Min Tan; Birong Lin; Sheng Hou; Weizhu Qian; Bohua Li; Dapeng Zhang; Bo Zhou; Hao Wang; Tongyu Zhu; Yajun Guo
Journal:  MAbs       Date:  2009 Jan-Feb       Impact factor: 5.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.